The Digital Radio Mondiale consortium is welcoming the announcement of a small and affordable radio receiver model that will be made in India.

CML Microsystems PLC - Essex, England-based developer of mixed-signal, radio frequency and microwave semiconductors for communications markets - Non-Executive Director Nathan Zommer buys 100,000 ...

亚盛医药-B发布公告，公司原创1类新药奥雷巴替尼（商品名：耐立克®）获国家药品监督管理局（NMPA）药品审评中心（CDE）纳入“突破性治疗品种”名单，用于联合化疗一线治疗新诊断费城染色体阳性（Ph+）急性淋巴细胞白血病（ALL）患者。

消息面上，亚盛医药-B发布公告，公司原创1类新药奥雷巴替尼 (商品名：耐立克®)获国家药品监督管理局 (NMPA)药品审评中心 (CDE)纳入“突破性治疗品种”名单，用于联合化疗一线治疗新诊断费城染色体阳性 (Ph+)急性淋巴细胞白血病 (ALL)患者。

IT services company TCS has collaborated with Vantage Towers, Europe’s second-largest telecom tower operator, to introduce a ...

The UK stock market has recently faced challenges, with the FTSE 100 index closing lower due to weak trade data from China, reflecting broader global economic concerns. Despite these hurdles, ...

Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia ...

The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...

Zydus Lifesciences shares surged 7% to an intraday high of Rs 947.95 on the BSE on Thursday after receiving final approval ...

Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...

智通财经APP讯，亚盛医药-B (06855)发布公告，公司原创1类新药奥雷巴替尼 (商品名：耐立克®)获国家药品监督管理局 (NMPA)药品审评中心 (CDE)纳入“突破性治疗品种”名单，用于联合化疗一线治疗新诊断费城染色体阳性 (Ph+)急性淋巴细胞白血病 (ALL)患者。